Clinical Trial Update: Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Azithromycin microspheres in low-risk community-acquired pneumonia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Azithromycin Microspheres (Azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Community-Acquired Pneumonia | Phase 3 | Status: COMPLETED